SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-004498
Filing Date
2018-04-02
Accepted
2018-04-02 16:44:57
Documents
5
Period of Report
2018-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 31249
2 ex99-1.htm EX-99.1 114658
3 ex99-2.htm EX-99.2 11831
4 ex99-2_001.jpg GRAPHIC 2388
5 ex99-3.htm EX-99.3 11577
  Complete submission text file 0001493152-18-004498.txt   173935
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 18729581
SIC: 2835 In Vitro & In Vivo Diagnostic Substances